NZ534919A - Bioactive keratin peptides - Google Patents

Bioactive keratin peptides

Info

Publication number
NZ534919A
NZ534919A NZ534919A NZ53491903A NZ534919A NZ 534919 A NZ534919 A NZ 534919A NZ 534919 A NZ534919 A NZ 534919A NZ 53491903 A NZ53491903 A NZ 53491903A NZ 534919 A NZ534919 A NZ 534919A
Authority
NZ
New Zealand
Prior art keywords
bioactive
keratin peptides
keratin
peptides
peptide
Prior art date
Application number
NZ534919A
Other languages
English (en)
Inventor
Donald R Cowsar
Original Assignee
Keraplast Tech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keraplast Tech Ltd filed Critical Keraplast Tech Ltd
Publication of NZ534919A publication Critical patent/NZ534919A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4741—Keratin; Cytokeratin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Birds (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
NZ534919A 2002-01-28 2003-01-28 Bioactive keratin peptides NZ534919A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35239602P 2002-01-28 2002-01-28
PCT/US2003/002645 WO2003064449A2 (en) 2002-01-28 2003-01-28 Bioactive keratin peptides

Publications (1)

Publication Number Publication Date
NZ534919A true NZ534919A (en) 2006-08-31

Family

ID=27663089

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ534919A NZ534919A (en) 2002-01-28 2003-01-28 Bioactive keratin peptides

Country Status (9)

Country Link
US (2) US7501485B2 (enExample)
EP (1) EP1478328B1 (enExample)
JP (2) JP2005516072A (enExample)
AU (1) AU2003210722B9 (enExample)
CA (1) CA2474723A1 (enExample)
DK (1) DK1478328T3 (enExample)
ES (1) ES2426420T3 (enExample)
NZ (1) NZ534919A (enExample)
WO (1) WO2003064449A2 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2474723A1 (en) * 2002-01-28 2003-08-07 Keraplast Technologies, Ltd. Bioactive keratin peptides
US7153822B2 (en) * 2002-01-29 2006-12-26 Wyeth Compositions and methods for modulating connexin hemichannels
US7439012B2 (en) 2004-08-17 2008-10-21 Wake Forest University Health Sciences Ambient stored blood plasma expanders containing keratose
CN100371017C (zh) * 2004-10-29 2008-02-27 肖应庆 生物角蛋白在制药中的应用
JP2006151940A (ja) * 2004-10-29 2006-06-15 Dainichiseika Color & Chem Mfg Co Ltd 細胞活性剤
US8920827B2 (en) * 2005-10-21 2014-12-30 Wake Forest University Health Sciences Keratin bioceramic compositions
US7202701B1 (en) * 2005-12-06 2007-04-10 Micrel, Inc. Input/output circuit for handling unconnected I/O pads
US7892573B2 (en) * 2006-02-10 2011-02-22 Wake Forest University Health Sciences Nerve regeneration employing keratin biomaterials
US8273702B2 (en) * 2006-02-17 2012-09-25 Wake Forest University Health Sciences Wound healing compositions containing keratin biomaterials
EP1983927B1 (en) * 2006-02-17 2014-11-05 Wake Forest University Health Sciences Coatings and biomedical implants formed from keratin biomaterials
JP2008019244A (ja) * 2006-06-13 2008-01-31 Dainichiseika Color & Chem Mfg Co Ltd 細胞活性剤
EP2502628B1 (en) * 2006-06-23 2016-12-14 Alethia Biotherapeutics Inc. Polynucleotides and polypeptide sequences involved in cancer
NZ549249A (en) * 2006-08-18 2009-10-30 Univ Massey Methods for reducing the incidence of mastitis by administration of keratin
PL227142B1 (pl) * 2006-11-21 2017-11-30 Inst Medycyny Doświadczalnej I Klinicznej Im M Mossakowskiego Polskiej Akademii Nauk Mikrostrukturalny preparat białkowy zawierajacy zwiazki biologicznie czynne
CN101730540A (zh) * 2007-04-17 2010-06-09 韦克福里斯特大学健康科学院 含有角蛋白生物材料的伤口愈合组合物
US9068162B2 (en) 2007-08-17 2015-06-30 Wake Forest University Health Sciences Keratin biomaterials for cell culture and methods of use
WO2010060186A1 (en) 2008-11-03 2010-06-03 Alethia Biotherapeutics Inc. Antibodies that specifically block the biological activity of a tumor antigen
US9045600B2 (en) 2009-05-13 2015-06-02 Keraplast Technologies, Ltd. Biopolymer materials
EP2542564B1 (en) 2010-03-05 2018-05-09 Wake Forest University Health Sciences Controlled delivery system
US8545893B2 (en) 2010-03-08 2013-10-01 Wake Forest University Health Sciences Keratin biomaterials for treatment of ischemia
US9505820B2 (en) * 2010-09-01 2016-11-29 Zotos International, Inc. Hair treatment composition with naturally - derived peptide identical to human hair
EP2640408B1 (en) 2010-11-17 2016-05-25 Wake Forest University Health Sciences Keratin compositions for treatment of bone deficiency or injury
PL226806B1 (pl) 2010-12-06 2017-09-29 Inst Medycyny Doświadczalnej I Klinicznej Im Mirosława Mossakowskiego Pan Preparaty peptydowe oraz peptydy odziałaniu przeciwnowotworowym
DK3173427T3 (da) 2011-03-31 2019-08-05 Adc Therapeutics Sa Antistoffer mod nyre-associeret antigen 1 og antigen-bindende fragmenter deraf
WO2012148720A2 (en) 2011-04-27 2012-11-01 The Regents Of The University Of California Anti-microbial peptides and methods of use thereof
WO2013025941A1 (en) 2011-08-17 2013-02-21 Keranetics Llc Low protein percentage gelling compositions
WO2013025940A1 (en) * 2011-08-17 2013-02-21 Keranetics Llc Angiogenesis promoted by alpha-keratose
WO2013025928A2 (en) 2011-08-17 2013-02-21 Keranetics Llc Methods for extracting keratin proteins
CN102952246B (zh) * 2011-08-18 2015-02-25 香港理工大学 角蛋白肽修饰的聚乙二醇水凝胶,其制备方法与应用
HRP20190946T1 (hr) 2012-01-09 2019-07-26 Adc Therapeutics Sa Sredstva za liječenje trostruko negativnog raka dojke
US9827245B2 (en) 2013-03-15 2017-11-28 KeraNetics, LLC Keratin compositions comprising halofuginone
US9226890B1 (en) 2013-12-10 2016-01-05 Englewood Lab, Llc Polysilicone base for scar treatment
US11273118B2 (en) 2014-06-04 2022-03-15 Zim Biosciences, Inc. Compositions and methods for improving skin quality
CN109415422B (zh) 2015-10-29 2022-08-16 庆北大学校产学协力团 超低分子角蛋白肽的制备方法及其的利用
WO2017074163A1 (ko) * 2015-10-29 2017-05-04 경북대학교 산학협력단 초저분자 케라틴 펩타이드의 제조 방법 및 그의 이용
CN105273051A (zh) * 2015-11-27 2016-01-27 东山博广天兴食品股份有限公司 一种利用双酶协同水解制备章鱼钙螯合蛋白肽的方法
KR102351515B1 (ko) * 2019-12-17 2022-01-14 (주)수파드엘릭사 아릴 탄화수소 수용체의 활성을 억제하는 폡타이드 및 이를 이용하는 화장료 조성물
KR102311325B1 (ko) 2020-01-08 2021-10-14 주식회사 에이더블유바이오 극성 저분자 케라틴 펩타이드를 유효성분으로 포함하는 피부 보습 또는 탄력 증진용 화장료 조성물

Family Cites Families (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US626999A (en) * 1899-06-13 Wire-feeding device
US922692A (en) 1907-10-07 1909-05-25 Byron B Goldsmith Thermoplastic keratin composition.
US926999A (en) 1907-11-25 1909-07-06 Carl Neuberg Process of producing digestible substances from keratin.
US922962A (en) * 1908-06-05 1909-05-25 Frederik Christian Schroeder Machine for gluing textile fabrics.
US960914A (en) 1909-09-21 1910-06-07 Arthur Heinemann Pills for the treatment of diabetes mellitus.
US1214299A (en) 1915-06-30 1917-01-30 William M Grosvenor Manufacturing colloids.
IT377232A (enExample) 1938-08-26 1900-01-01
US2434688A (en) 1942-11-03 1948-01-20 Ralph L Evans Regenerated keratin
US2447860A (en) 1944-11-07 1948-08-24 Us Agriculture Method of dispersing keratin proteins and the composition resulting therefrom
US2517572A (en) 1948-11-23 1950-08-08 Chase B Jones Process of utilizing detergents to solubilize keratin materials
US2814851A (en) 1953-12-11 1957-12-03 Rubberset Company Keratin treating process and products thereof
US3033755A (en) 1961-04-14 1962-05-08 Kolmar Laboratories Process for removing the water soluble materials from a keratin structure and cosmetic or pharmaceutical product formed therefrom
US3655416A (en) 1968-12-18 1972-04-11 Lever Brothers Ltd Lipid-protein membrane and process
US3642498A (en) 1969-09-18 1972-02-15 Gen Mills Inc Method of preparing keratin-containing films and coatings
US4178361A (en) 1973-09-10 1979-12-11 Union Corporation Sustained release pharmaceutical composition
JPS54124043A (en) 1978-03-20 1979-09-26 Kuraray Co Ltd Emulsification of liquid cis-1, 4-polyisoprene rubber
JPS5785308A (en) 1980-11-17 1982-05-28 Kao Corp Hair rinse composition
JPS5790910A (en) * 1980-11-27 1982-06-05 Toshiba Corp Method for monitoring water content in oil in oil filled electric equipment
JPS5791910A (en) 1980-11-28 1982-06-08 Kao Corp Preshampoo-type hair treatment composition
JPS57109797A (en) 1980-12-26 1982-07-08 Kao Corp Preparation of low-molecular weight keratinous substance
JPS57130910A (en) 1981-02-05 1982-08-13 Kao Corp Hair treatment agent
JPS57144213A (en) 1981-03-03 1982-09-06 Kao Corp Hair treatment
US4357274A (en) 1981-08-06 1982-11-02 Intermedicat Gmbh Process for the manufacture of sclero protein transplants with increased biological stability
US4570629A (en) 1982-03-17 1986-02-18 University Of Illinois Foundation Hydrophilic biopolymeric copolyelectrolytes, and biodegradable wound dressing comprising same
FR2540381B1 (fr) * 1983-02-08 1986-05-30 Dior Sa Parfums Christian Procede pour stimuler la croissance des cellules; composition cosmetique, pharmaceutique et composition complementaire pour milieu de culture cellulaire appliquant ce procede
LU85081A1 (fr) 1983-11-09 1985-07-17 Oreal Medicament et composition medicamenteuse pour le traitement et/ou la prevention des maladies de la peau mettant en jeu un processus inflammatoire
JPS60220068A (ja) 1984-04-16 1985-11-02 テルモ株式会社 生体被覆膜
JPS621731A (ja) 1985-06-28 1987-01-07 Nippon Zeon Co Ltd 成形品の脱臭方法
DK528285D0 (da) * 1985-11-15 1985-11-15 Novo Industri As Peptider samt praeparater indeholdende disse
JPS6347470A (ja) 1986-08-12 1988-02-29 株式会社神戸製鋼所 壁タテ筋の先組工法
JPS63202582A (ja) 1987-02-13 1988-08-22 株式会社日立製作所 スクリユウ駆動式エレベ−タ
US5047249A (en) 1988-07-22 1991-09-10 John Morris Co., Inc. Compositions and methods for treating skin conditions and promoting wound healing
ATE118350T1 (de) * 1988-07-22 1995-03-15 Morris John Co Inc Zusammensetzungen und verfahren zur behandlung von hautkrankheiten und zur aktivierung der wundheilung.
JPH02212410A (ja) 1989-02-14 1990-08-23 Mandamu:Kk アルカリ処理毛髪のコンディショニング組成剤
JPH0311099A (ja) 1989-06-06 1991-01-18 Seiwa Kasei:Kk ケラチン加水分解物、その製造方法および上記ケラチン加水分解物からなる化粧品基剤
IL95393A0 (en) 1989-08-18 1991-06-30 John Morris Co Odor-masked and stabilized compositions for treating keratinous tissue,skin conditions,and promoting wound healing
JP2748174B2 (ja) 1990-01-29 1998-05-06 株式会社成和化成 化粧品基剤
FR2661414B1 (fr) 1990-04-25 1995-03-24 Michel Jean Pierre Produit a base de keratines modifiees, son procede de preparation et les applications notamment en medecine humaine ou veterinaire.
JPH04174659A (ja) 1990-08-06 1992-06-22 Olympus Optical Co Ltd 側枝血管閉塞具
JPH0482561A (ja) 1990-07-26 1992-03-16 Niigata High Supinaa Kk 創傷被覆材
JPH0491138A (ja) 1990-08-06 1992-03-24 Fujimori Kogyo Kk ケラチンフィルムの製造方法
JP3047923B2 (ja) 1990-11-16 2000-06-05 武田薬品工業株式会社 ケラチン有機溶媒液およびその製造法
GB9121815D0 (en) * 1991-10-15 1991-11-27 Delta Biotechnology Ltd Medicine
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
JP3094182B2 (ja) 1992-04-09 2000-10-03 清 山内 ケラチンｓ−スルフォ塩を壁構成原料として用いるマイクロカプセル及びその製造方法
JP3094181B2 (ja) 1992-04-09 2000-10-03 清 山内 再生天然ケラチンを壁材とするマイクロカプセル及びその製造方法
JP3138838B2 (ja) 1992-04-30 2001-02-26 東レ・ダウコーニング・シリコーン株式会社 混合粉体の製造方法
JP3283302B2 (ja) 1992-09-22 2002-05-20 株式会社成和化成 還元ケラチンの製造方法
JPH06116300A (ja) 1992-10-07 1994-04-26 Seiwa Kasei:Kk ケラチンフラグメントおよびその製造方法
JP3250858B2 (ja) 1993-02-15 2002-01-28 ライオン株式会社 ケラチン繊維処理組成物
JP3223207B2 (ja) 1993-02-26 2001-10-29 本田技研工業株式会社 連結装置
CN1105029A (zh) 1993-05-24 1995-07-12 花王株式会社 制备溶解蛋白质的方法
JP3518691B2 (ja) 1993-05-25 2004-04-12 清 山内 動物クチクル細胞由来の不溶性還元タンパク質、その製造方法および上記動物クチクル細胞由来の不溶性還元タンパク質を原料として作製された高分子成形品
US5527773A (en) * 1993-08-25 1996-06-18 United States Of America Use of synthetic peptides to disrupt the cytoskeleton
US5691179A (en) * 1993-08-26 1997-11-25 Washington University Cell death regulators
US5965536A (en) * 1993-12-15 1999-10-12 Board Of Regents, The University Of Texas System Methods of inhibiting CXC intercrine molecules
JP3446979B2 (ja) 1994-12-06 2003-09-16 株式会社成和化成 水溶性整髪料
US5634945A (en) 1995-03-02 1997-06-03 Pernia; Luis R. Biological filler and use of same
GB9506926D0 (en) 1995-04-04 1995-05-24 Croda Int Plc Cystine-siicone copolymers and their use for treating keratin substrates
US6586570B1 (en) * 1996-01-11 2003-07-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US5712252A (en) 1996-03-08 1998-01-27 The University Of Tennessee Research Corporation Method of augmenting soft tissue in mammals
US6110889A (en) * 1996-06-14 2000-08-29 Board Of Regents, The University Of Texas System Peptide tumor cell growth inhibitors
RU2108079C1 (ru) 1996-08-16 1998-04-10 Василий Александрович Мензул Способ лечения ожоговых ран
RU2106154C1 (ru) 1996-08-16 1998-03-10 Василий Александрович Мензул Перевязочный материал
US6063061A (en) 1996-08-27 2000-05-16 Fusion Medical Technologies, Inc. Fragmented polymeric compositions and methods for their use
JP3891509B2 (ja) 1997-04-18 2007-03-14 清 山内 高等動物体毛由来の還元タンパク質またはその水性媒体分散物およびその製造方法
JPH10337466A (ja) 1997-06-04 1998-12-22 Akuseenu Kk ケラチンマイクロカプセル及びその製造方法並びにケラチンマイクロカプセルを含有する化粧料
JPH11240822A (ja) 1998-02-24 1999-09-07 Shiseido Co Ltd 毛髪処理剤
WO1999054345A1 (en) * 1998-04-21 1999-10-28 Thomas Jefferson University Cd8 antagonists
US6270791B1 (en) * 1999-06-11 2001-08-07 Keraplast Technologies, Ltd. Soluble keratin peptide
JP2001087754A (ja) 1999-09-24 2001-04-03 Relief Fund For Oil Pollution Damage In Fishing Ground 汚染土壌の生物的修復用粉状組成物
KR100312178B1 (ko) 1999-10-06 2001-11-03 서경배 신규한 아미노산 실리콘 폴리머들, 그의 제조방법, 아미노산 실리콘 폴리머로 표면개질된 화장료용 분체 및 이를 함유하는 색조화장료 조성물
JP2002138022A (ja) 2000-10-27 2002-05-14 Seiwa Kasei:Kk 毛髪化粧料および毛髪処理法
CN1298733C (zh) 2001-07-17 2007-02-07 凯瑞泰克有限公司 制造可溶性角蛋白衍生物
BR0212389A (pt) 2001-08-31 2004-08-17 Keratec Ltd Produção de materiais biopolìmeros como pelìcula, fibra, espuma ou adesivo a partir de derivados solúveis de queratina s-sulfonada
CA2474723A1 (en) * 2002-01-28 2003-08-07 Keraplast Technologies, Ltd. Bioactive keratin peptides

Also Published As

Publication number Publication date
AU2003210722B2 (en) 2008-03-06
EP1478328B1 (en) 2013-06-05
EP1478328A2 (en) 2004-11-24
US7501485B2 (en) 2009-03-10
ES2426420T3 (es) 2013-10-23
EP1478328A4 (en) 2009-08-26
WO2003064449A3 (en) 2004-09-23
US20110070276A1 (en) 2011-03-24
WO2003064449A2 (en) 2003-08-07
US20030228353A1 (en) 2003-12-11
US8324346B2 (en) 2012-12-04
JP2010155859A (ja) 2010-07-15
CA2474723A1 (en) 2003-08-07
AU2003210722B9 (en) 2008-05-01
DK1478328T3 (da) 2013-07-22
AU2003210722A2 (en) 2003-09-02
JP2005516072A (ja) 2005-06-02

Similar Documents

Publication Publication Date Title
NZ534919A (en) Bioactive keratin peptides
PT1171143E (pt) Extracto peptidico de tremoco e composicao farmaceutica ou cosmetica ou nutraceutica compreendendo o referido extracto
MY142354A (en) Acidic insulin preparations having improved stability
ITMI20020399A0 (it) Composizioni dietetiche e/o farmaceutiche per uso umano e/o animale abase di preparati microbici probiotici
NO960682L (no) Silikonpodede termoplastiske elastomere kopolymerer og hår- og hudpleiepreparater inneholdende slike
AU2003222347A1 (en) Novel peptide derivatives, preparation and therapeutic and cosmetic application thereof
DE69922822D1 (de) Rekombinante haarbehandlungsmittel
AU2002358653A1 (en) Cosmetic and/or pharmaceutical sunscreen preparations
AU2001264515A1 (en) Melphalan derivatives and their use as cancer chemotherapeutic drugs
EP4209500A4 (en) PEPTIDE, COSMETIC COMPOSITION AND PHARMACEUTICAL COMPOSITION COMPRISING IT
AU2002365396A1 (en) Peptides, peptide compositions,and methods of use in binding p 185
MXPA03010684A (es) Peptidos y el uso de los mismos para oscurecer la piel.
EP1088547A3 (de) Wirkstoffkombinationen bzw. Addukte aus Biotin und/oder Biotinderivaten und Cyclodextrinen und Verwendung solcher Wirkstoffkombinationen in kosmetischen Zubereitungen
DE60025026D1 (de) Antimicrobielle wirkung des ersten kationischen cluster des menschlichen lactoferrins
EP1173476A4 (en) SOYBEAN PROTEIN NUTRIENTS
ES2181592B1 (es) Uso de glicoproteina para el tratamiento y re-epitelizacion de heridas
ITMI942663A0 (it) Proteine ricche in idrossiprolina e formulazioni farmaceutiche e cosmetiche che le compongono
AU2003292326A1 (en) Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser
DK1165102T3 (da) Matrixproteinpræparater til podning i ikke-mineraliseret væv
HUP0201696A3 (en) Cyclic peptides, pharmaceutical compositions comprising thereof and their use
AU2003221096A1 (en) Peptides, medicinal compositions containing the peptide and medicinal compositions for treating cancer
AU3739500A (en) Protease resistant flint analogs
EP1583545A4 (en) PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF PEPTIDES OF HIV GP41 AND ITS THERAPEUTIC USE
WO2002066492A3 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques.
WO2001074320A3 (de) Verwendung von protease-inhibitoren in der kosmetik und pharmazie

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 JAN 2017 BY CPA GLOBAL

Effective date: 20151222

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 JAN 2018 BY CPA GLOBAL

Effective date: 20161217

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 JAN 2019 BY CPA GLOBAL

Effective date: 20171214

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 JAN 2020 BY CPA GLOBAL

Effective date: 20181213

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 JAN 2021 BY CPA GLOBAL

Effective date: 20191212

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 JAN 2022 BY CPA GLOBAL

Effective date: 20201218

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 JAN 2023 BY CPA GLOBAL

Effective date: 20211216

EXPY Patent expired